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ORIGINAL ARTICLEHostility and Physiological Responses to Acute
Stress in People With Type 2 Diabetes
Ruth A. Hackett, MSc, Antonio I. Lazzarino, MD, Livia A. Carvalho, PhD, Mark Hamer, PhD,
and Andrew Steptoe, DScABSTRACTObjective: Hostility is associated with cardiovascular mortality and morbidity, and one of the mechanisms may involve
heightened reactivity to mental stress. However, little research has been conducted in populations at high risk for cardiovas-
cular disease. The aim of the present study was to assess the relationship between hostility and acute stress responsivity in
individuals with Type 2 diabetes.
Methods: A total of 140 individuals (median age [standard deviation] 63.71 [7.00] years) with Type 2 diabetes took part
in laboratory-based experimental stress testing. Systolic blood pressure, diastolic blood pressure, heart rate, plasma
interleukin-6 (IL-6), and salivary cortisol were assessed at baseline, during two stress tasks, and 45 and 75 minutes later.
Cynical hostility was assessed using the Cook Medley Cynical Hostility Scale.
Results: Participants with greater hostility scores had heightened increases in IL-6 induced by the acute stress tasks
(B = 0.082, p = .002), independent of age, sex, body mass index, smoking, household income, time of testing, medica-
tion, and baseline IL-6. Hostility was inversely associated with cortisol output poststress (B = −0.017, p = .002), independent
of covariates. No associations between hostility and blood pressure or heart rate responses were observed.
Conclusions: Hostile individuals with Type 2 diabetes may be susceptible to stress-induced increases in inflammation.
Further research is needed to understand if such changes increase the risk of cardiovascular disease in this population.
Key words: Type 2 diabetes mellitus, hostility, interleukin-6, salivary cortisol, psychological stress.AUC = area under the curve, BMI = body mass index, CAD = cor-
onary artery disease, CI = confidence intervals, CVD = cardiovas-
cular disease, DBP = diastolic blood pressure, HbA1c = glycated
hemoglobin, HR = heart rate, IL-6 = interleukin-6, SBP = systolic
blood pressure, T2DM = Type 2 diabetes mellitusINTRODUCTION
Hostility is a trait that is typically conceptualized as anegative cynical attitude toward others, with a propen-
sity for anger or aggression (1). The impact of hostility on
health has become increasingly well recognized. Several
studies have identified hostility as an independent risk factor
for all-cause mortality (2). In particular, hostility has been
suggested to play a role in cardiovascular disease (CVD).
Results from a meta-analysis of prospective cohort studies
indicate that hostility is associated with an increased risk of
CVD in initially healthy populations, as well as poorer prog-
nosis in patients with CVD (3). There is evidence that acute
episodes of anger can trigger myocardial infarction and sud-
den cardiac death (4). In addition to cardiac events, hostility
has been implicated in the long-term development of coronary
atherosclerosis. Prospective associations between hostility and
carotid atherosclerosis, as indexed by intima-media thickness,
have been reported in both male and female samples (5,6).From the Department of Epidemiology and Public Health, University Colle
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health, the underlying mechanisms involved are not well
understood. One possibility is that the relationship is medi-
ated through behavioral pathways. Hostility may lead to
adverse health behaviors, such as poor diet, sedentary life-
style, smoking, and excessive alcohol consumption (7),
all of which are established risk factors for CVD. However,
findings from most studies remain significant after adjusting
for health behaviors (2,3). Thus, it may be that direct biolog-
ical mechanisms are involved.
In epidemiologic studies, hostility has been linked
with disturbances across multiple biological systems.
High levels of hostility have been associated withge London, London, UK.
partment of Epidemiology and Public Health, University College London,
c.uk
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Hostility, Acute Stress, and Type 2 Diabetesautonomic dysfunction (8,9), inflammation (10,11), and
increased platelet activation (12).
Acute mental stress testing is another research strategy
that is used to investigate the biological concomitants of
hostility. Mental stress testing involves the measurement
of biological responses to acute challenges. This method al-
lows detailed dynamic responses to be studied under con-
trolled conditions, reducing the impact of other factors
that may confound associations (13).
Most of research in the field has investigated cardiovascu-
lar responses to acute stress. Meta-analytic results indicate
that heightened cardiovascular stress responsivity is associ-
ated with an increased risk of future CVD (14) and hostility
has been associated with heightened cardiovascular stress re-
sponses in healthy participants (15).
CVD has been characterized as an inflammatory con-
dition. Heightened inflammatory interleukin-6 (IL-6)
concentrations have been prospectively associated with
future CVD and poor outcomes in patients with existing
CVD (16,17). In addition, positive associations between
circulating IL-6 concentrations and hostility have been
observed (10,11).
Excessive glucocorticoid action is associated with cardio-
vascular risk factors such as central obesity (18), insulin re-
sistance (19), and hypertension (20). Cortisol is involved in
regulating inflammation through activation of the glucocorti-
coid receptor, leading to inhibition of inflammatory cytokine
production by monocytes (21). However, prolonged expo-
sure to heightened cortisol levels may result in dysregulation
of this systemmanifested through insufficient glucocorticoid
signaling (21). Hostility has been associated with flattening
of cortisol rhythms in some studies (22,23). Evidence indi-
cates that low cortisol responders have significantly higher
cytokine responses to acute stress (24). Thus, diminished
cortisol levels may facilitate heightened inflammation asso-
ciated with ill health.
Despite this evidence, few studies have investigated in-
flammatory and neuroendocrine mechanisms in relation to
hostility, and most of research has been conducted with
healthy samples. To our knowledge, only one small study
has investigated acute stress responses in a sample at high
risk for coronary events (25). In this study, more hostile
individuals with advanced coronary artery disease (CAD)
had heightened systolic blood pressure (SBP) and diastolic
blood pressure (DBP) responses to mental stress tasks.
Hostility was also positively associated with IL-6 and
negatively correlated with cortisol concentrations during
poststress recovery.
Type 2 diabetes mellitus (T2DM) is a chronic metabolic
disease that is becoming increasingly prevalent globally
(26). CVD is a major cause ofmortality andmorbidity in in-
dividuals with T2DM (27). Results from a meta-analysis of
102 prospective studies indicate that patients with T2DM
have a two-fold excess risk of developing CVD comparedPsychosomatic Medicine, V 77 • 458-466 459
Copyright © 2015 by the American Psychosomatic Society.with controls, independent of standard risk factors (28).
This additional risk is largely unexplained. Therefore, it is
possible that personality factors could potentially play a
role in linking the conditions.
Hostility is not well researched in relation to T2DM.
However, it has been associated prospectively with raised
fasting glucose (29) and cross sectionally with insulin resis-
tance (30), glycated hemoglobin (HbA1c), and prevalent
T2DM (31). In addition, angry temperament has been linked
with T2DM onset 6 years later (32). Taken together, it is
plausible that hostility plays a role in T2DM and that it
may contribute to the increased risk CVD in people with
the condition.
Considering the excess risk of CVD in this population
and the lack of research relating hostility and inflammatory
and neuroendocrine stress responses, we investigated the
relationship between hostility and SBP, DBP, heart rate
(HR), IL-6, and cortisol responses to laboratory stress in a
sample of individuals with T2DM. In epidemiologic stud-
ies, raised IL-6 levels have been prospectively associated
with CVD development (16) and poorer outcomes in pa-
tients with CVD (17). Inflammation is involved in the path-
ogenesis of T2DM, and IL-6 and C-reactive protein are the
most widely studied markers in the field. Meta-analytic re-
sults indicate that heightened IL-6 rather than C-reactive
protein is a stronger predictor of subsequent diabetes in ini-
tially healthy samples (33) and that concentrations of IL-6
are elevated in patients with T2DM (34). We predicted that
participants with greater hostility scores would have greater
cardiovascular and IL-6 responses to acute stress. Neuroen-
docrine dysfunction is suggested to play a role in T2DM,
and recent results from a comparative study of individuals
with diabetes and healthy controls indicate that cortisol
stress responsivity is blunted in T2DM (35). We predicted
that more hostile individuals would have more diminished
cortisol responses to stress.METHODS
Participants
Participants in this study were recruited as part of a larger trial
comparing individuals with Type 2 diabetes and healthy controls
(35). We recruited 140 people aged 50 to 75 years with doctor-
diagnosed Type 2 diabetes from diabetic outpatient and primary
care clinics in the London area between March 2011 and July
2012. Enrollment was restricted to patients without a history or
previous diagnosis of coronary heart disease, inflammatory dis-
eases, allergies, or mood disorders. In the 7 days before testing,
all participants were prohibited from taking anti-inflammatory
or antihistaminemedication. On the day of testing, we rescheduled
participants if they reported colds or other infections. We
instructed participants to avoid caffeinated beverages and smoking
for at least 2 hours before the session and to avoid vigorous exer-
cise and alcohol from the previous evening. All participants gaveMay 2015
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ORIGINAL ARTICLEfull informed consent to take part in the study, and ethical approval
was granted by the National Research Ethics Service.
Psychological Measures
We measured cynical hostility using the 10-item Cook Medley
Cynical Hostility Scale (1). The Cynical Hostility scale is a widely
used self-report measure of hostility, assessing cynical and mis-
trustful attitudes toward others, and has previously been related
to physiological stress responses (15,25). The items (e.g., “I think
most people would lie to get ahead” and “It is safer to trust no
one”) were scored using a binary (true/false) format. Total scores
ranged from 0 to 10, with higher scores indicating greater hostility.
The internal consistency (Cronbach α) of the scale was .80 in this
sample. Depression was measured using the Center for Epidemio-
logic Studies Depression Scale, a standard measure of depressive
symptomatology (36). The Cronbach α of the scale was .86 in this
sample. Subjective stress was measured over the course of the lab-
oratory session using a 7-point rating scale, with higher values in-
dicating greater stress.
Other Measures
This study was part of a larger trial of physiological response to stress
in people with diabetes and included other measures that are not de-
scribed here (35). For the purposes of the present analysis, we mea-
sured household income as an indicator of socioeconomic status,
and participants were categorized into low (<£20,000), medium
(£20,000-40,000), and high (≥£40,000) income groups. Participant
smoking status and medication use were also recorded. Medication
was allocated to seven categories: oral diabetic medication (metformin,
etc), insulin and other injected diabetic medication, aspirin, β-blockers,
other hypertensive medication (angiotensin-converting enzyme
inhibitors, calcium-channel blockers, etc), and statins.
Mental Stress Tasks
Mental stress was induced in the laboratory with two 5-minute be-
havioral tasks administered in random order. The first was a com-
puterized version of the Stroop color-word interference task,
which involved successive presentation of target color words
(e.g., green and blue) printed in an incongruous color. The second
task was mirror tracing, which involved tracing a star that could
only be seen in mirror image using a mental stylus. When the sty-
lus came off the star, a mistake was registered and a loud beep was
emitted by the device (Lafayette Instruments Corp, Lafayette, IN).
Participants were told that the average person could complete five
circuits of the star in the allocated time. These tasks were selected
because they have previously been shown to stimulate similar ap-
praisals of involvement and engagement from participants across
the social gradients and have been used in a number of previous
studies in our laboratory (37).
Procedure
We tested participants individually in a light- and temperature-
controlled laboratory. Sessions were held either in the morning
or in the afternoon. At the beginning of the session, anthropomet-
ric measures were obtained using standardized techniques and
body mass index (BMI) was computed. Participants were fitted
with a finger cuff so that SBP, DBP, and HR could be continuously
monitored using a Finometer device (TNO-TPD BiomedicalPsychosomatic Medicine, V 77 • 458-466 460
Copyright © 2015 by the American Psychosomatic Society.Instrumentation, Amsterdam, Holland), and a venous cannula
was inserted for the collection of blood samples. The participant
rested for 30 minutes, and the last 5 minutes of data was averaged
to constitute baseline cardiovascular values. At this time, a base-
line blood sample was drawn, saliva was collected for the analysis
of cortisol, and a subjective stress rating was obtained.We then ad-
ministered the two 5-minute behavioral tasks. Five-minute record-
ings of SBP, DBP, and HRweremade during each of the tasks, and
subjective stress ratings and blood and saliva samples were taken
immediately after the tasks. Monitoring of posttask recovery con-
tinued for 75 minutes. Further subjective stress ratings, cardiovas-
cular measurements, and blood samples were obtained at 45 and
75 minutes posttasks. Additional saliva samples were obtained at
20, 45, and 75 minutes after the tasks.Biological Measures
Blood samples were collected in EDTA tubes and centrifuged im-
mediately at 2500 rpm for 10minutes at room temperature. Plasma
was removed from the tube and aliquoted into 0.5-ml portions and
stored at −80°C until analysis. Plasma IL-6 was assayed using a
Quantikine high-sensitivity two-site enzyme-linked immunosor-
bent assay from R&D Systems (Oxford, UK). The sensitivity of
the assay ranged from 0.016 to 0.110 pg/ml, and the intra-assay
and interassay coefficients of variation were 7.3% and 7.7%, re-
spectively. Cortisol was assessed from saliva samples using a
time-resolved immunoassay with fluorescence detection, at the
University of Dresden. The intra-assay and interassay coefficients
of variation were less than 8%.Statistical Analysis
We averaged SBP, DBP, and HR into 5-minute means for baseline,
the two tasks, and the two recovery periods. The two task trials
were subsequently averaged. Plasma IL-6 values were normally
distributed, but cortisol values were skewed and so were log-10
transformed before analysis. The pattern of cortisol over the labo-
ratory session was analyzed using individual values, and also by
computing cortisol area under the curve (AUC) with respect to
ground using procedures described by Pruessner et al. (38).
Responses to mental stress testing were analyzed using
repeated-measures analysis of variance. Subjective stress, cardio-
vascular variables, and IL-6 were analyzed across four trials (base-
line, task, and 45 minutes and 75 minutes poststress), and cortisol
was analyzed across five trials (baseline, task, and 20 minutes,
45 minutes, and 75 minutes posttask). Associations with hostility
were analyzed using multiple regression. Multivariable linear re-
gressions on baseline values of SBP, DBP, HR, and IL-6, and re-
gressions on responses after stress were carried out. Cortisol was
analyzed using individual values and AUC to investigate total cor-
tisol output across the whole session. For analyses of associations
with baseline values, hostility was entered into the regression
models along with age, sex, BMI, smoking, household in-
come, time of laboratory testing, oral antidiabetic medication,
and β-blockers. These covariates were chosen because previ-
ous research has indicated that these factors might influence phys-
iological function (37,39–41) and preliminary analyses indicated
that these variables were correlated with the physiological re-
sponses assessed in this study.May 2015
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TABLE 1. Participant Characteristics
Characteristics
Age, M (SD), y 63.71 (7.00)
Sex, n (%), % men 88 (62.9)
Ethnicity, n (%), % white 112 (80)
Current smoker, n (%) 20 (14.4)
Body mass index, M (SD), kg/m2 30.75 (5.72)
Waist, M (SD), cm 105.50 (13.49)
Household income, n (%)
<£20,000 (approximately $33,286) 57 (42.9)
£20,000–40,000 (approximately
$33,286–66,573)
38 (28.6)
>£40,000 (approximately $66,573) 38 (28.6)
Cook Medley Cynical Hostility
(10 items), M (SD)
3.77 (2.8)
CES-D, M (SD) 11.85 (8.9)
HbA1c, M (SD), % 7.25 (1.42)
Oral antidiabetic, n (%) 109 (80.1)
Injectable antidiabetic and insulin, n (%) 15 (11.0)
β-Blockers, n (%) 16 (11.8)
M = mean; SD = standard deviation; CES-D = Center for Epidemiologic
Studies Depression Scale; HbA1c = glycated hemoglobin.
Hostility, Acute Stress, and Type 2 DiabetesAssociations of hostility with stress reactivity and recovery in-
volved regressions onto changes between baseline and task or
posttask values and included the baseline level of the dependent
variable as an additional covariate.
We conducted preliminary analyses to check whether other fac-
tors influenced the relationship between hostility and physiologi-
cal function. We investigated whether there was a relationship
between HbA1c and hostility as well as responses to stress. These
analyses were nonsignificant and are therefore not presented in this
article. We also investigated whether hostility interacted with sex,
but found no significant associations with physiological responses,
so interaction terms were not included in the final models. Most of
the sample was obese, and we therefore investigated whether BMI
interacted with hostility but found no significant associations with
physiological responses. The present sample included 28 (20%)
nonwhite individuals. Adding ethnicity as a factor to the analyses
did not alter the results, so it was not included in the models de-
scribed here. Depressed mood was also assessed in the study and
was significantly correlated with hostility (p < .001). We investi-
gated whether hostility interacted with depression, but found no
significant associations with physiological responses. In addition,
adding depression as an extra covariate did not affect the pattern
of results. Therefore, depression was not included in the final
models. As participants were taking medication at the time
of testing, we assessed whether antidiabetic medication and
β-blockers interacted with hostility. Hostility did not interact
with antidiabetics, but we found a significant interaction be-
tween β-blockers and hostility for some of the cardiovascular
responses. However, inclusion of this interaction term did not
affect the pattern of physiological responses, so this variable
was not retained for the final analyses.
Results are presented as unstandardized regression coefficients
(B) with 95% confidence intervals (CIs) using continuous hostility
scores as the predictor variable. Significant effects from the regres-
sion analyses are illustrated by comparing high- and low-hostility
groups defined by a median spilt (cutoff ≥ 4) using analysis of co-
variance. All analyses were conducted using SPSS version 21
(SPSS, Chicago, IL).
RESULTS
Participant Characteristics
The sample consisted of 140 people (88men and 52 women)
with Type 2 diabetes. Participant characteristics are detailed
in Table 1. Participants were aged 63.71 (7.00) years on av-
erage and were predominately white with relatively low in-
comes. BMI ranged from 19.2 to 47.80 kg/m2, and the
average BMI was in the obese range (BMI >30 kg/m2).
Levels of HbA1c were less than 6.5% in 29.9% of the sam-
ple, between 6.5% and 7.5% in 41%, and more than 7.5% in
29.1% of participants. Hostility scores averaged 3.77 (2.8)
and were not related to age, sex, ethnicity, BMI, waist cir-
cumference, smoking, or medication use at the time of test-
ing (p values > .136). However, there was an association
with household income (χ2 = 8.08, p = .018). Hostility was
greater among participants with household incomes less than
£20,000 (mean = 4.2 [2.88]) and between £20,000 andPsychosomatic Medicine, V 77 • 458-466 461
Copyright © 2015 by the American Psychosomatic Society.40,000 (4.01 [3.07]) than that among participants with in-
comes more than £40,000 (2.81 [2.22]).
Responses to Stress
Details of participants' subjective and biological responses
to stress are presented in Table 2. We found significant main
effects of trial for SBP, DBP, HR, IL-6, cortisol, and subjec-
tive stress levels (p values < .001). The tasks elicited substan-
tial cardiovascular reactions, with an average rise of 23.27
(15.89) mmHg in SBP and 12.51 (7.00) mmHg in DBP. Al-
though blood pressure (BP) returned toward baseline during
the posttask period, both SBP and DBP remained elevated
above baseline levels at 45 and 75 minutes after tasks. We
found that HR also increased significantly in response to
the tasks, with an average rise of 4.56 (4.67) beats/min.
IL-6 increased after the tasks with a notable delay consistent
with previous stress studies (42), reaching the highest values
at 75 minutes posttask. The pattern of response was different
for cortisol; levels fell significantly in response to the tasks
with an average decrease of 1.29 (0.08) nM immediately
posttask and 2.3 (0.13) nM 20 minutes posttask. There were
marked individual differences in this stress response, with
changes in cortisol ranging from 0.23 to −6.54 nM posttask
and from −0.44 to −12.28 nM at 20 minutes posttask. Partic-
ipants’ subjective stress levels increased during the tasks and
returned to low levels during recovery. There were no signif-
icant relationships between hostility and any of the subjec-
tive stress ratings (p values > .05).May 2015
 Unauthorized reproduction of this article is prohibited.
TABLE 2. Subjective and Biological Responses to Stress
Baseline Task 20 min 45 min 75 min
Subjective stress 1.49 (0.08)a 4.49 (0.13)b 1.53 (0.08)a 1.43 (0.08)a
SBP, mm Hg 126.08 (1.16)a 149.35 (1.76)b 134.24 (1.74)c 137.05 (1.46)d
DBP, mm Hg 71.74 (0.87)a 84.25 (1.07)b 78.04 (1.27)c 79.51 (1.18)d
HR, beats/min 71.77 (1.04)a 76.33 (1.04)b 70.18 (1.04)c 70.15 (1.02)d
IL-6, pg/ml 2.08 (0.11)a 2.07 (0.11)a 2.18 (0.12)a 2.31 (0.12)b
Cortisol, nM 10.03 (0.47)a 8.74 (0.39)b 7.74 (0.34)c 6.89 (0.36)d 7.17 (0.49)c
SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate; IL-6 = interleukin-6.
Values are presented as means (standard deviation).
a,b,c Values in rows with different superscripts are significantly different from one another (p < .05).
ORIGINAL ARTICLEHostility and Biological Responses to Stress
There was no association between hostility and baseline
levels of SBP, DBP, or HR (B values between −0.376 and
−0.088 and p values > .113). Similarly, BP or HR responses
to the task or recovery from the tasks were not related to hos-
tility (B values between −0.0826 and 0.236 and p values >
.113). There was no association between hostility and base-
line plasma IL-6 concentrations (B = −0.015, CI = −0.095
to 0.064, p = .703). However, regressions on the change in
IL-6 between baseline and 45 minutes posttask (B = 0.082,
CI = 0.032-0.132, p = .002) and 75 minutes posttask (B =
0.076, CI = 0.021-0.131, p = .007) show larger increases in
more hostile participants. These effects were independent
of baseline IL-6, age, sex, BMI, smoking, household in-
come, time of testing, β-blockers, and oral antidiabetic med-
ications. The association between hostility and IL-6 levels
over the laboratory session is illustrated in Figure 1, where
participants in the study have been divided into high- and
low-hostility groups. Greater hostility was associated with
larger plasma IL-6 increases after stress.
In the analyses of cortisol, there was again no association
with hostility at baseline (B = −0.002, CI = −0.016 to 0.011,
p = .747). However, cortisol concentration at 20 minutes
posttask (B = −0.017, CI = −0.027 to −0.006, p = .002),FIGURE 1. IL-6 stress responses for high-hostility (light gray
line) and low-hostility groups (dark gray line) during baseline,
speech and mirror tasks, and recovery. Values are adjusted for
age, sex, BMI, smoking, household income, β-blockers, and oral
antidiabetic medications. Error bars indicate standard error of
mean. IL-6 = interleukin-6; BMI = body mass index.
Psychosomatic Medicine, V 77 • 458-466 462
Copyright © 2015 by the American Psychosomatic Society.45 minutes posttask (B = −0.018, CI = −0.032 to −0.005,
p = .010), and 75 minutes after tasks (B = −0.023, CI =
−0.037 to −0.009, p = .002) was lower inmore hostile individ-
uals after adjustment for covariates. The association between
hostility and cortisol was further examined using the cortisol
AUCmeasure. There was an inverse association between hos-
tility and cortisol AUC (B = −26.69, CI = −41.39 to −11.98,
p < .001). The difference in cortisol levels between partici-
pants with high and low hostility scores is illustrated in
Figure 2. Cortisol levels declined across the laboratory session
in both groups. However, higher hostility was associated with
a significantly greater decrease in cortisol output over the test-
ing period.Intercorrelation Between IL-6 and Cortisol
In light of the associations between hostility and IL-6 and
cortisol responses to stress, we assessed the intercorrelations
between IL-6 and cortisol. The change in IL-6 in responses
to the tasks at 45 and 75minutes was significantly negatively
correlated with cortisol AUC (r = −0.35 and −0.38, p
values < .001) and with all individual cortisol measurements
over the laboratory session (r values between −0.19 and
−0.29, all p values < .05).FIGURE 2. Cortisol stress responses for high-hostility (light gray
line) and low-hostility groups (dark gray line) during baseline,
speech and mirror tasks, and recovery. Values are adjusted for
age, sex, BMI, smoking, household income, β-blockers, and oral
antidiabetic medications. Error bars indicate standard error of
mean. BMI = body mass index.
May 2015
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Hostility, Acute Stress, and Type 2 DiabetesDISCUSSION
This study investigated the relationship between hostility
and cardiovascular, inflammatory, and neuroendocrine re-
sponses to acute stress in people with T2DM. We predicted
that participants with greater hostility scores would be more
responsive to stress. The main finding is that greater hostil-
ity was associated with elevated IL-6 responses to acute
stress. By contrast, cortisol output after stress was dimin-
ished to a greater extent in more hostile individuals. These
associations were independent of baseline values, age,
sex, BMI, smoking, household income, antidiabetic medi-
cations, and β-blockers. Contrary to prediction, we did
not observe any associations between hostility and BP or
HR responses.
IL-6 responses to stress were significantly elevated in
participants with T2DM with greater hostility ratings. This
result corroborates previous work from our group in which
IL-6 was elevated after acute stress in more hostile patients
with CAD (25). Only one other study has investigated in-
flammatory stress responses in relation to hostility.
Brummett et al. (43) examined the effects of hostility on
IL-6 responses to an emotional recall stressor in 525 healthy
participants, but found no association.
This discrepancy in findings may reflect variation in the
study population. The current investigation and the study
by Brydon et al. (25) assessed IL-6 responsivity in two
high-risk phenotype samples, whereas Brummett et al.
(43) used a healthy participant group. It may be that height-
ened inflammatory stress responses are only associated
with hostility in groups with an increased propensity for
CVD. Further studies will be required to assess the impact
of the study population on the presence of an association
between hostility and inflammation. Nevertheless, the re-
sults of the current analysis suggest that more hostile indi-
viduals with T2DM may be susceptible to stress-induced
inflammation.
We observed no relationship between hostility and car-
diovascular responses to stress in this T2DM sample. This
result is paradoxical as a considerable body of evidence in-
dicates that heightened cardiovascular stress responsivity is
associated with hostility in healthy individuals (15,44–46).
Indeed, in our previous analysis of patients with CAD,
greater hostility was associated with increased SBP and
DBP responses to laboratory stress (25). The lack of associ-
ation seen in the present analysis cannot be attributed to the
intensity of stressor used, as both subjective stress ratings
and cardiovascular measures increased significantly in re-
sponse to the task. It is unlikely that the current studywas un-
derpowered to detect cardiovascular effects. We used the
same laboratory procedure as our study of 34 patients with
CAD (25), and associations have been reported in other anal-
yses with much smaller sample sizes than the present study
(44). Our analysis also took account statistically of medica-
tions, and a number of previous studies have found no effectPsychosomatic Medicine, V 77 • 458-466 463
Copyright © 2015 by the American Psychosomatic Society.of β-blockers on cardiovascular responses to stress (47).
However, we cannot rule out the possibility that the null as-
sociation observed was attributable to medication, as the
participants with T2DM continued to take β-blockers and
antidiabetic medications at the time of testing.
We found that cortisol output after stress was attenuated
in participants with T2DMwith greater hostility scores. The
observed inverse relationship between cortisol AUC and
hostility is consistent with the findings of our previous anal-
ysis in which cortisol levels were reduced poststress in
more hostile participants with CAD (25). It is plausible that
decreased cortisol levels may have facilitated the elevated
IL-6 responses observed in more hostile participants in both
studies. However, this relationship has not been consis-
tently observed. In a study of 52 healthy men, high levels
of hostility were associated with heightened cortisol responses
to an anagram task, but only in those who simultaneously ex-
perienced harassing comments from the experimenter (46).
The task used in the present analysis was designed to elicit
general stress responses, whereas the task in the study by
Suarez et al. (46) was designed to provoke hostile reactions,
and this may account for the diverging findings.
Our results observed in a laboratory environment offer
the possibility that the negative impact of hostility on health
could be mediated, in part, through stress-related dysregu-
lation of the neuroendocrine and inflammatory systems.
Cortisol levels declined significantly throughout the labora-
tory session in all participants, which may be indicative of
neuroendocrine dysfunction in individuals with T2DM. El-
evated cortisol levels assessed from single plasma (48) and
24-hour urinary-free samples (49) have been associated with
higher plasma glucose concentrations and insulin resistance
(48,49), and T2DM is a recognized complication of long-
term cortisol excess as seen in Cushing syndrome (50) and
in glucocorticoid-treated patients (51). Recently, high levels
of hair cortisol have been correlated with 3.2-fold increased
risk of T2DM in a community sample (52). There is emerg-
ing evidence that diurnal cortisol secretion may be altered in
individuals with T2DM. In a recent study of 3508 community-
dwelling individuals, we showed that T2DMwas associated
with a flatter slope in cortisol across the day (53). Although
in a subsample of the Multi-Ethnic Study of Atherosclerosis,
individuals with T2DM exhibited a blunted cortisol awaken-
ing response relative to controls (54).
Peripheral glucocorticoid regulation is critical for the
maintenance of homeostasis, and cortisol plays a pivotal
role in many physiological processes relevant to diabetes.
Cortisol directly triggers hepatic gluconeogenesis, pro-
motes lipolysis, and the release of fatty free acids into the
circulation and the accumulation of triglycerides in adipose
tissue. It directly reduces insulin sensitivity and decreases
insulin secretion by acting through glucocorticoid recep-
tors, which are expressed on pancreatic β-cells (55). An-
other way in which neuroendocrine dysfunction may playMay 2015
 Unauthorized reproduction of this article is prohibited.
ORIGINAL ARTICLEa role in diabetes is through circadian disruption. Circadian
rhythms are regulated at the hypothalamic level by the su-
prachiasmatic nuclei. It has been suggested that distur-
bances in circadian rhythms may act on T2DM through
the alteration of glucose metabolism. Indeed, recent exper-
imental work indicates that circadian disruption heightens
both fasting and postprandial plasma glucose levels through
inadequate pancreatic insulin secretion (56).
Despite the literature highlighting the role of neuroendo-
crine dysfunction in T2DM, little research has assessed dy-
namic physiological stress responses in this population.
The participants in the present study were part of a larger
trial comparing biological responses to stress in individuals
with T2DM and healthy controls (35). Results from this
trial indicate that participants with diabetes have blunted
cortisol responses to stress compared with healthy individ-
uals. The current study suggests that greater levels of hostil-
ity exaggerate disturbances in neuroendocrine function in
this population.
Cortisol is also involved in the regulation of inflamma-
tion and chronic exposure to psychosocial stress results in
increased cortisol secretion (57). Cortisol typically has an
inhibitory effect on proinflammatory cytokine production.
However, long-term heightened cortisol concentrations
may result in dysregulation of this system manifested
through insufficient glucocorticoid signaling (21). In this
case, reduced cortisol levels may have a permission effect
on inflammatory markers. In the current investigation, hos-
tility was inversely associated with cortisol output over the
laboratory session. Other evidence indicates that high
cortisol responders have significantly smaller cytokine
responses to acute stress (24). Our findings suggest
that more hostile people with T2DM show insufficient glu-
cocorticoid signaling to inhibit inflammatory responses un-
der stress due to decreased hormone release. This decreased
cortisol production may have contributed to the heightened
IL-6 stress responses observed in more hostile participants.
The acute changes observed in this study offer the possi-
bility that inflammation may be one of the mechanisms
through which hostility confers an increased risk for ill
health. Although we found no association between hostility
and baseline IL-6 in our sample, large cohort studies have
reported a relationship (10,11). Post hoc power calculations
(data not shown) revealed that the present study was under
powered to detect basal differences in IL-6, which might
explain why the association between IL-6 and hostility only
emerged when induced by stress. In epidemiologic studies,
raised IL-6 levels have been prospectively associated with
CVD development (16) and poorer outcomes in patients
with CVD (17). Inflammation also plays a role in the path-
ogenesis of T2DM. Heightened circulating IL-6 levels are
predictive of T2DM development in initially healthy sam-
ples (33), and concentrations are elevated in patients with
T2DM (34).Psychosomatic Medicine, V 77 • 458-466 464
Copyright © 2015 by the American Psychosomatic Society.It is possible that hostility might potentially contribute to
increase the risk for CVD in people with T2DM through dys-
regulated stress-related inflammatory pathways. In this way,
hostility may contribute to insulin resistance and dyslipid-
emia, as elevated IL-6 concentrations inhibit AMP-activated
protein kinase, an enzyme involved in insulin-stimulated
fatty acid oxidation, down-regulating gene transcription of
proteins involved in insulin-stimulated glucose transport
and lipid uptake in adipose tissue (34). However, prospec-
tive studies will be required to test this pathway.
The present study is not without limitations. The partic-
ipants were patients with T2DM without a history of coro-
nary heart disease recruited from the London area, and most
were of white European origin. Therefore, the results may
not apply to other groups. Most of the participants were tak-
ing medications at the time of testing. Analyses took ac-
count statistically of medications; however, an effect of
medication on stress reactivity cannot be excluded. The
study was cross sectional in nature, so it is not possible to
infer causality. Longitudinal research is needed to elucidate
the degree to which trait hostility and changes in hostility
over time are associated with inflammatory, neuroendo-
crine, and cardiovascular processes, as well as negative
health outcomes in people with T2DM. Finally, the study
was limited by use of a self-report measure to assess hostil-
ity. The assessment of observable hostile behavior could
provide a different perspective in understanding the rela-
tionship between hostility and stress reactivity.
Despite these considerations, the results suggest that re-
sponses to stress are dysregulated in more hostile individuals
with T2DM. We observed greater IL-6 stress responses and
diminished cortisol output over the laboratory session in
more hostile diabetic individuals, independent of covariates.
It is possible that heightened stress-induced inflammation
may increase the risk for CVD in this population. However,
further studies are required to confirm this pathway.
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